Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
P2Y12 Blocking Peptide (AC1357)
Cat.#: ACPP-1357
Specifications
Despition P2Y12 Blocking Peptide for Immunodepletion, Immunocompetition SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1742 Human PRND Protein (AC1742) 2 µg inquiry ACPP-1411 Human NDEL1 Protein (AC1411) 2 µg inquiry ACPP-1661 Human HEXA Protein, Sf9 (AC1661) 2 µg inquiry ACPP-1699 Human Human Prealbumin (Active) Protein (AC1699) 1 mg inquiry ACPP-1494 beta Catenin Blocking Peptide (AC1494) 250 µg inquiry ACPP-1668 Human BDNF Protein, His (AC1668) 5 µg inquiry ACPP-1197 Dopamine Transporter Blocking Peptide (AC1197) 250 µg inquiry ACPP-1249 TMPRSS2 Blocking Peptide (AC1249) 250 µg inquiry ACPP-1433 Human Interleukin 6 (Active) Protein (AC1433) 100 µg inquiry ACPP-1504 Human CPLX1 Protein (AC1504) 10 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket